Sidoti Csr Issues Positive Forecast for USNA Earnings

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Analysts at Sidoti Csr lifted their Q1 2026 earnings estimates for shares of USANA Health Sciences in a research report issued to clients and investors on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will post earnings of $0.91 per share for the quarter, up from their previous estimate of $0.82. The consensus estimate for USANA Health Sciences' current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences' Q2 2026 earnings at $0.88 EPS and Q3 2026 earnings at $0.91 EPS.

Several other analysts have also recently commented on the stock. DA Davidson upgraded shares of USANA Health Sciences to a "hold" rating in a research note on Friday, December 20th. StockNews.com raised USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research note on Thursday, December 19th.

USANA Health Sciences Trading Up 8.0 %

Shares of NYSE USNA traded up $2.72 during midday trading on Wednesday, reaching $36.66. 106,151 shares of the company were exchanged, compared to its average volume of 84,489. The stock has a fifty day simple moving average of $37.89 and a 200 day simple moving average of $40.04. The stock has a market cap of $698.74 million, a P/E ratio of 12.95, a PEG ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a 1 year low of $31.44 and a 1 year high of $54.81.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same quarter last year, the company posted $0.59 EPS.

Insiders Place Their Bets

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the business's stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently bought and sold shares of USNA. Pzena Investment Management LLC raised its position in shares of USANA Health Sciences by 24.4% in the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company's stock worth $44,183,000 after buying an additional 191,289 shares during the period. Pacer Advisors Inc. boosted its stake in shares of USANA Health Sciences by 16.5% in the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company's stock valued at $20,638,000 after purchasing an additional 76,904 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company's stock valued at $1,472,000 after purchasing an additional 38,547 shares in the last quarter. Deerfield Management Company L.P. Series C increased its stake in USANA Health Sciences by 297.0% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company's stock worth $1,346,000 after buying an additional 22,251 shares during the period. Finally, WINTON GROUP Ltd acquired a new position in USANA Health Sciences in the 2nd quarter worth $890,000. Institutional investors and hedge funds own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.